4.7 Review

β-Amyloid, Blood Vessels, and Brain Function

Journal

STROKE
Volume 40, Issue 7, Pages 2601-2606

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.108.536839

Keywords

Alzheimer disease; cerebral amyloid angiopathy; vascular cognitive impairment

Funding

  1. National Institute of Neurological Disorders and Stroke [R01 NS062028, K24 NS056207, R01 NS042147]
  2. Canadian Stroke Network
  3. National Institute of Aging [R01 AG026484, R01 AG021084]
  4. Alzheimer's Association

Ask authors/readers for more resources

Cerebrovascular disease and Alzheimer disease are common diseases of aging and frequently coexist in the same brain. Accumulating evidence suggests that the presence of brain infarction, including silent infarction, influences the course of Alzheimer disease. Conversely, there is evidence that beta-amyloid can impair blood vessel function. Vascular beta-amyloid deposition, also known as cerebral amyloid angiopathy, is associated with vascular dysfunction in animal and human studies. Alzheimer disease is associated with morphological changes in capillary networks, and soluble beta-amyloid produces abnormal vascular responses to physiological and pharmacological stimuli. In this review, we discuss current evidence linking beta-amyloid metabolism with vascular function and morphological changes in animals and humans. (Stroke. 2009; 40: 2601-2606.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available